Walgreens will begin selling genetic testing kits throughout their 7,500 nationwide locations (albeit, not in New York due to state laws) in mid-May. The kits, which cost between $20 and $30, will include saliva collection tools and a pre-paid envelope. Pathway Genomics, the maker of the kits will test for genetic predisposition to diseases like Alzheimer’s, Tay-Sachs, and cystic fibrosis.
Pathway also sells testing kits for allergies to common pharmaceutical drugs, pregnancy planning, and miscellaneous other health conditions, but those tests will not be available at Walgreens and cost upwards of $79 (to as much as $249). In a statement from Pathway Genomics, Jim Plante, the company’s CEO said, “We’re revolutionizing the way people access information about their genetics,” said Plante. “The value of knowing how genes play a role in our personal lives, and potentially the lives of our children, is critical for making well-informed health and wellness decisions.”
While there are health benefits to early detection of life threatening illnesses, such as breast cancer, or finding out about a potentially deadly drug reaction before its administration, not every genetic test is as valuable as Plante indicates. I understand that there is health value to availing people to the ability to learn of impending genetic disorders, but that does not mean that people should test for everything. I personally do not want to live in fear of developing symptoms of a disease that I have a genetic proclivity to developing in the future. More time, money, and effort should be placed into researching cures for diseases to help the future generations, not more ways to detect potential for growing into a disease. If there are no (or very limited) benefits to treating diseases early, then the money could be better appropriated elsewhere.
Science technology is increasing, which is a good thing, but not every technology should be economically exploited.